{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:44:00Z","timestamp":1777081440361,"version":"3.51.4"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008900","name":"University of South Florida","doi-asserted-by":"publisher","award":["GME Research Grant"],"award-info":[{"award-number":["GME Research Grant"]}],"id":[{"id":"10.13039\/100008900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009164","name":"Moffitt Cancer Center","doi-asserted-by":"publisher","award":["Center of Excellence for Evolutionary Therapy"],"award-info":[{"award-number":["Center of Excellence for Evolutionary Therapy"]}],"id":[{"id":"10.13039\/100009164","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer stem cells (CSC) are hypothesized to promote tumor progression through innate chemoresistance and self-renewal. CSCs reside in the CD34+\/CD38\u2212 immunophenotypic subpopulation of acute myeloid leukemia (AML). Isolation of CSCs from B-lymphoblastic leukemia (B-ALL) has proven difficult, and the cells of interest apparently are not isolated to the CD34+\/CD38\u2212 compartment. This may be explained, in part, by temporal variations of CD34 and CD38 expression which result in stochastic cell state transitions (e.g., from CD34+\/CD38+ to CD34+\/CD38\u2212). We present a mathematical model of these transitions and correlate salient findings with BCR::ABL1 status, minimal residual disease (MRD), and relapse in adult B-ALL. As the CSC hypothesis is well supported in AML, we focus on transitions to and from the hematopoietic stem cell compartment (CD34+\/CD38\u2212). Our analysis suggests the presence of dedifferentiating transitions to a CD34+\/CD38\u2212 stem cell\u2013like immunophenotype, especially in B-ALL with BCR::ABL1. In contrast, BCR::ABL1-negative patient samples have low CD34+\/CD38\u2212 self-renewal rates and either high CD34+\/CD38+ or CD34\u2212\/CD38+ incoming rates. High CD34+\/CD38\u2212 self-renewal is also associated with positive MRD following induction chemotherapy. We find a lack of observable changes in cell state transitions between diagnosis and relapse specimens. Furthermore, simulated therapies targeting the stem cell\u2013like compartment indicate that blocking transitions to the CD34+\/CD38\u2212 state (i.e., blocking dedifferentiation) is more effective than promoting transitions from the CD34+\/CD38\u2212 state toward other states (i.e., promoting differentiation) to reduce the proportion of CD34+\/CD38\u2212 cells. The modeling framework used here is a novel, useful tool to infer prognosis and genotype from routine flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Flow cytometry characterization of B-ALL samples (diagnosis, remission, and relapse) is used to parameterize a mathematical model of cell state transition rates and stratify patients for post-induction chemotherapy MRD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0277","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:55:01Z","timestamp":1764172501000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-5339","authenticated-orcid":false,"given":"Curtis","family":"Gravenmier","sequence":"first","affiliation":[{"name":"1Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-017X","authenticated-orcid":false,"given":"Sadegh","family":"Marzban","sequence":"additional","affiliation":[{"name":"2Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2248-1978","authenticated-orcid":false,"given":"Yi-Han","family":"Tang","sequence":"additional","affiliation":[{"name":"3Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-8490","authenticated-orcid":false,"given":"Nancy","family":"Gillis","sequence":"additional","affiliation":[{"name":"3Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."},{"name":"4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4328-6021","authenticated-orcid":false,"given":"Bijal D.","family":"Shah","sequence":"additional","affiliation":[{"name":"4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2609-4063","authenticated-orcid":false,"given":"Lynn C.","family":"Moscinski","sequence":"additional","affiliation":[{"name":"1Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-1458","authenticated-orcid":false,"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-4664","authenticated-orcid":false,"given":"Jeffrey","family":"West","sequence":"additional","affiliation":[{"name":"2Integrated Mathematical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"2026010702154282100_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"2026010702154282100_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"2026010702154282100_bib3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.leu.2404131","article-title":"Preferential expression of a high number of ATP binding cassette transporters in both normal and leukemic CD34+CD38\u2212 cells","volume":"20","author":"de Grouw","year":"2006","journal-title":"Leukemia"},{"key":"2026010702154282100_bib4","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s43018-020-00126-z","article-title":"Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells","volume":"1","author":"Stevens","year":"2020","journal-title":"Nat Cancer"},{"key":"2026010702154282100_bib5","doi-asserted-by":"crossref","first-page":"e107587","DOI":"10.1371\/journal.pone.0107587","article-title":"Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemia","volume":"9","author":"Terwijn","year":"2014","journal-title":"PLoS One"},{"key":"2026010702154282100_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjh.14991","article-title":"Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients","volume":"183","author":"Hanekamp","year":"2018","journal-title":"Br J Haematol"},{"key":"2026010702154282100_bib7","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","article-title":"High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival","volume":"11","author":"van Rhenen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2026010702154282100_bib8","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2016-02-695312","article-title":"Evolution of acute myelogenous leukemia stem cell properties after treatment and progression","volume":"128","author":"Ho","year":"2016","journal-title":"Blood"},{"key":"2026010702154282100_bib9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/leu.2008.83","article-title":"CD34+CD38+CD19+ as well as CD34+CD38\u2212CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL","volume":"22","author":"Kong","year":"2008","journal-title":"Leukemia"},{"key":"2026010702154282100_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13045-016-0310-1","article-title":"Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized","volume":"9","author":"Jiang","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2026010702154282100_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood-2014-03-563304","article-title":"Identification of CD34+ and CD34\u2212 leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia","volume":"125","author":"Aoki","year":"2015","journal-title":"Blood"},{"key":"2026010702154282100_bib12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V78.3.830.830","article-title":"Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin\u2019s lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial","volume":"78","author":"Lazarus","year":"1991","journal-title":"Blood"},{"key":"2026010702154282100_bib13","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/leu.2016.315","article-title":"Plastic CD34 and CD38 expression in adult B\u2013cell precursor acute lymphoblastic leukemia explains ambiguity of leukemia-initiating stem cell populations","volume":"31","author":"Lang","year":"2017","journal-title":"Leukemia"},{"key":"2026010702154282100_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/10428194.2013.807924","article-title":"High proportion of CD34+\/CD38\u2212cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia","volume":"55","author":"Long","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2026010702154282100_bib15","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.leukres.2010.03.023","article-title":"High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia","volume":"34","author":"Ebinger","year":"2010","journal-title":"Leuk Res"},{"key":"2026010702154282100_bib16","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3109\/10428194.2013.778404","article-title":"Frequencies of immature CD34+CD38\u2212 and CD34+CD38\u2212CD19+ blasts correlate with minimal residual disease level in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"54","author":"Shman","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2026010702154282100_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.leu.2402060","article-title":"Adult precursor B-ALL with BCR\/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expresssion","volume":"15","author":"Tabernero","year":"2001","journal-title":"Leukemia"},{"key":"2026010702154282100_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood-2018-08-835355","article-title":"New insights into hematopoietic differentiation landscapes from single-cell RNA sequencing","volume":"133","author":"Watcham","year":"2019","journal-title":"Blood"},{"key":"2026010702154282100_bib19","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1093\/nar\/gkaa725","article-title":"Inference and multiscale model of epithelial-to-mesenchymal transition via single-cell transcriptomic data","volume":"48","author":"Sha","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026010702154282100_bib20","doi-asserted-by":"crossref","first-page":"1177932217712241","DOI":"10.1177\/1177932217712241","article-title":"CellTrans: an R package to quantify stochastic cell state transitions","volume":"11","author":"Buder","year":"2017","journal-title":"Bioinform Biol Insights"},{"key":"2026010702154282100_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","article-title":"Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells","volume":"146","author":"Gupta","year":"2011","journal-title":"Cell"},{"key":"2026010702154282100_bib22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.annonc.2023.08.008","article-title":"Treatment of evolving cancers will require dynamic decision support","volume":"34","author":"Strobl","year":"2023","journal-title":"Ann Oncol"},{"key":"2026010702154282100_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tcb.2022.10.006","article-title":"Agent-based methods facilitate integrative science in cancer","volume":"33","author":"West","year":"2023","journal-title":"Trends Cell Biol"},{"key":"2026010702154282100_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1109\/JPROC.2021.3136715","article-title":"The hallmarks of mathematical oncology","volume":"110","author":"Bull","year":"2022","journal-title":"Proc IEEE"},{"key":"2026010702154282100_bib25","doi-asserted-by":"crossref","first-page":"e1010319","DOI":"10.1371\/journal.pcbi.1010319","article-title":"A model for the intrinsic limit of cancer therapy: duality of treatment-induced cell death and treatment-induced stemness","volume":"18","author":"Angelini","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"2026010702154282100_bib26","doi-asserted-by":"crossref","first-page":"031501","DOI":"10.1088\/1478-3975\/ac4ee2","article-title":"Roadmap on plasticity and epigenetics in cancer","volume":"19","author":"Foo","year":"2022","journal-title":"Phys Biol"},{"key":"2026010702154282100_bib27","doi-asserted-by":"crossref","first-page":"110162","DOI":"10.1016\/j.jtbi.2020.110162","article-title":"Understanding the role of phenotypic switching in cancer drug resistance","volume":"490","author":"Gunnarsson","year":"2020","journal-title":"J Theor Biol"},{"key":"2026010702154282100_bib28","doi-asserted-by":"crossref","first-page":"110812","DOI":"10.1016\/j.jtbi.2021.110812","article-title":"Global analysis of a cancer model with drug resistance due to Lamarckian induction and microvesicle transfer","volume":"527","author":"D\u00e9nes","year":"2021","journal-title":"J Theor Biol"},{"key":"2026010702154282100_bib29","doi-asserted-by":"crossref","first-page":"e110714","DOI":"10.1371\/journal.pone.0110714","article-title":"Nonequilibrium population dynamics of phenotype conversion of cancer cells","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS OnE"},{"key":"2026010702154282100_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40778-023-00224-5","article-title":"Understanding hematopoietic stem cell dynamics\u2014insights from mathematical modelling","volume":"9","author":"Pedersen","year":"2023","journal-title":"Curr Stem Cell Rep"},{"key":"2026010702154282100_bib31","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"key":"2026010702154282100_bib32","doi-asserted-by":"crossref","first-page":"RP89780","DOI":"10.7554\/eLife.89780","article-title":"Measures of genetic diversification in somatic tissues at bulk and single-cell resolution","volume":"12","author":"Moeller","year":"2024","journal-title":"Elife"},{"key":"2026010702154282100_bib33","doi-asserted-by":"crossref","first-page":"110620","DOI":"10.1016\/j.jtbi.2021.110620","article-title":"Mathematical modelling of the hematopoietic stem cell-niche system: clonal dominance based on stem cell fitness","volume":"518","author":"Pedersen","year":"2021","journal-title":"J Theor Biol"},{"key":"2026010702154282100_bib34","doi-asserted-by":"crossref","first-page":"1384509","DOI":"10.3389\/fimmu.2024.1384509","article-title":"Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms","volume":"15","author":"Boklund","year":"2024","journal-title":"Front Immunol"},{"key":"2026010702154282100_bib35","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1038\/s41467-024-54711-2","article-title":"Developmental hematopoietic stem cell variation explains clonal hematopoiesis later in life","volume":"15","author":"Kreger","year":"2024","journal-title":"Nat Commun"},{"key":"2026010702154282100_bib36","doi-asserted-by":"crossref","first-page":"640.e1","DOI":"10.1016\/j.jtct.2023.07.021","article-title":"Pilot study of donor-engrafted clonal hematopoiesis evolution and clinical outcomes in allogeneic hematopoietic cell transplantation recipients using a national registry","volume":"29","author":"Gillis","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"2026010702154282100_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/EBC20220038","article-title":"Stochastic population dynamics of cancer stemness and adaptive response to therapies","volume":"66","author":"Jain","year":"2022","journal-title":"Essays Biochem"},{"key":"2026010702154282100_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12064-023-00410-3","article-title":"Modeling stress-induced responses: plasticity in continuous state space and gradual clonal evolution","volume":"143","author":"Bukkuri","year":"2024","journal-title":"Theor Biosci"},{"key":"2026010702154282100_bib39","doi-asserted-by":"crossref","first-page":"104317","DOI":"10.1016\/j.isci.2022.104317","article-title":"Emergence of hybrid states of stem-like cancer cells correlates with poor prognosis in oral cancer","volume":"25","author":"Vipparthi","year":"2022","journal-title":"iScience"},{"key":"2026010702154282100_bib40","doi-asserted-by":"crossref","first-page":"13679","DOI":"10.1073\/pnas.1712064115","article-title":"Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance","volume":"114","author":"Su","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"2026010702154282100_bib41","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s42003-022-04208-9","article-title":"A lineage tree-based hidden Markov model quantifies cellular heterogeneity and plasticity","volume":"5","author":"Mohammadi","year":"2022","journal-title":"Commun Biol"},{"key":"2026010702154282100_bib42","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1158\/2159-8290.CD-21-0282","article-title":"Mapping phenotypic plasticity upon the cancer cell state landscape using manifold learning","volume":"12","author":"Burkhardt","year":"2022","journal-title":"Cancer Discov"},{"issue":"Suppl 1","key":"2026010702154282100_bib43","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.30707\/LiB5.2Cho","article-title":"Modelling acute myeloid leukaemia in a continuum of differentiation states","volume":"5","author":"Cho","year":"2018","journal-title":"Lett Biomath"},{"key":"2026010702154282100_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/psp4.13278","article-title":"A tutorial on pharmacometric Markov models","volume":"14","author":"Ooi","year":"2025","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"2026010702154282100_bib45","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1158\/0008-5472.CAN-20-0354","article-title":"State-transition analysis of time-sequential gene expression identifies critical points that predict development of acute myeloid leukemia","volume":"80","author":"Rockne","year":"2020","journal-title":"Cancer Res"},{"key":"2026010702154282100_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41375-024-02142-9","article-title":"State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia","volume":"38","author":"Frankhouser","year":"2024","journal-title":"Leukemia"},{"key":"2026010702154282100_bib47","doi-asserted-by":"crossref","first-page":"e34637","DOI":"10.1371\/journal.pone.0034637","article-title":"A stochastic Markov chain model to describe lung cancer growth and metastasis","volume":"7","author":"Newton","year":"2012","journal-title":"PLoS One"},{"key":"2026010702154282100_bib48","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1158\/0008-5472.CAN-12-4488","article-title":"Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model","volume":"73","author":"Newton","year":"2013","journal-title":"Cancer Res"},{"key":"2026010702154282100_bib49","doi-asserted-by":"crossref","first-page":"109831","DOI":"10.1016\/j.compbiomed.2025.109831","article-title":"Computational flow cytometry immunophenotyping at diagnosis is unable to predict relapse in childhood B-cell Acute Lymphoblastic Leukemia","volume":"188","author":"Mart\u00ednez-Rubio","year":"2025","journal-title":"Comput Biol Med"},{"key":"2026010702154282100_bib50","doi-asserted-by":"crossref","first-page":"1213009","DOI":"10.3389\/fped.2023.1213009","article-title":"Can CD34+CD38\u2212 lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?","volume":"11","author":"Stolpa","year":"2023","journal-title":"Front Pediatr"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0277\/3703529\/crc-25-0277.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/1\/47\/3723658\/crc-25-0277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/1\/47\/3723658\/crc-25-0277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:15:58Z","timestamp":1767770158000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/1\/47\/771471\/Cell-State-Transitions-Drive-the-Evolution-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0277","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.31016063","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016096","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016075","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016087","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016054","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016066","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016099","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016081","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016093","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016060","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016072","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016084","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016090","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016078","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016057","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016069","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.31016102","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8233673","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}